Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 3
1977 2
1978 3
1979 5
1980 3
1981 5
1983 3
1984 3
1985 4
1986 1
1987 3
1988 3
1989 1
1990 7
1991 2
1992 2
1993 4
1994 7
1995 2
1996 5
1997 5
1998 4
1999 10
2000 3
2001 6
2002 5
2003 5
2004 5
2005 4
2006 8
2007 13
2008 12
2009 14
2010 20
2011 16
2012 18
2013 21
2014 25
2015 28
2016 25
2017 22
2018 23
2019 39
2020 37
2021 31
2022 35
2023 47
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Results by year

Filters applied: . Clear all
Page 1
In reply to Schnabel et al.
Abdallah FW, Hussain N, Brull R. Abdallah FW, et al. Reg Anesth Pain Med. 2022 Jan;47(1):72-73. doi: 10.1136/rapm-2021-102725. Epub 2021 Mar 31. Reg Anesth Pain Med. 2022. PMID: 33790045 No abstract available.
MiRNA-93: a novel signature in human disorders and drug resistance.
Hussen BM, Abdullah SR, Rasul MF, Jawhar ZH, Faraj GSH, Kiani A, Taheri M. Hussen BM, et al. Cell Commun Signal. 2023 Apr 19;21(1):79. doi: 10.1186/s12964-023-01106-3. Cell Commun Signal. 2023. PMID: 37076893 Free PMC article. Review.
The aim of the current review is to provide an overview of miRNA-93's function in cancer disorder progression and non-cancer disorders, with a focus on dysregulated signaling pathways. We also give an overview of this miRNA's function as a biomarker of prognosis in …
The aim of the current review is to provide an overview of miRNA-93's function in cancer disorder progression and non-cancer disorder …
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies.
Faraj JA, Al-Athari AJH, Mohie SED, Kadhim IK, Jawad NM, Abbas WJ, Jalil AT. Faraj JA, et al. Med Oncol. 2022 Sep 29;39(12):239. doi: 10.1007/s12032-022-01842-5. Med Oncol. 2022. PMID: 36175691 Review.
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination, immune cell-based therapy, and cytokines were developed to engage the patient's immune system against cancer and better survival of them. While potent, however, preclinical and clinical dat …
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination, immune cell-based therapy, and cytokines were developed …
The Scoliosis Research Society adult spinal deformity standard outcome set.
de Kleuver M, Faraj SSA, Haanstra TM, Wright AK, Polly DW, van Hooff ML, Glassman SD; COSSCO study group. de Kleuver M, et al. Spine Deform. 2021 Sep;9(5):1211-1221. doi: 10.1007/s43390-021-00334-2. Epub 2021 Apr 6. Spine Deform. 2021. PMID: 33822320 Free PMC article. Review.
Telemedicine in Neurology: Challenges and Opportunities.
Al-Faraj A, Ukonu N, Mohtar O, Jha V, Chen DT, Vincent Lau KH. Al-Faraj A, et al. Res Sq [Preprint]. 2023 Oct 27:rs.3.rs-3470381. doi: 10.21203/rs.3.rs-3470381/v1. Res Sq. 2023. PMID: 37961526 Free PMC article. Preprint.
Among the challenges that hindered patients' ability to participate in telemedicine visits, 95% of neurologists rated patients' technological challenges with setting up telemedicine to be the most common issue encountered, 37% of neurologists rated patient's cognitive/ment …
Among the challenges that hindered patients' ability to participate in telemedicine visits, 95% of neurologists rated patients' technologica …
512 results